1
|
Ferlay J, Soerjomataran I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide, sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386.
2015.PubMed/NCBI View Article : Google Scholar
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020.PubMed/NCBI View Article : Google Scholar
|
3
|
Lou F, Huang J, Sima CS, Dycoco J, Rusch V
and Bach PB: Patterns of recurrence and second primary lung cancer
in early-stage lung cancer survivors followed with routine computed
tomography surveillance. J Thorac Cardiovasc Surg. 145:75–81.
2013.PubMed/NCBI View Article : Google Scholar
|
4
|
Sekihara K, Hishida T, Yoshida J, Oki T,
Omori T, Katsumata S, Ueda T, Miyoshi T, Goto M, Nakasone S,
Ichikawa T, et al: Long-term survival outcome after postoperative
recurrence of non-small-cell lung cancer: who is ‘cured’ from
postoperative recurrence? Eur J Cardiothorac Surg. 52:522–528.
2017.PubMed/NCBI View Article : Google Scholar
|
5
|
Quint LE, Tummala S, Brisson LJ, Francis
IR, Krupnick AS, Kazerooni EA, Iannettoni MD, Whyte RI and Orringer
MB: Distribution of distant metastasis from newly diagnosed
non-small cell lung cancer. Ann Thorac Surg. 62:246–250.
1996.PubMed/NCBI View Article : Google Scholar
|
6
|
Ichinose Y, Yano T, Yokoyama H, Inoue T,
Asoh H, Tayama K and Takanashi N: Postrecurrent survival of
patients with non-small-cell lung cancer undergoing a complete
resection. J Thorac Cardiovasc Surg. 108:158–61. 1994.PubMed/NCBI
|
7
|
Papa A, Rossi L, Verrico M, Di Cristofano
C, Moretti V, Strudel M, Zoratto F, Minozzi M and Tomao S: Breast
metastasis and lung large-cell neuroendocrine carcinoma: First
clinical observation. Clin Respir J. 11:574–578. 2017.PubMed/NCBI View Article : Google Scholar
|
8
|
Rimner A and Rosenzweig KE: Palliative
radiation for lung cancer metastasis to the breast: Two case
reports. J Thorac Oncol. 2:1133–1135. 2007.PubMed/NCBI View Article : Google Scholar
|
9
|
Crona J, Granberg D, Norlén O, Wärnberg F,
Stålberg P, Hellman P and Björklund P: Metastases from
neuroendocrine tumors to the breast are more common than previously
thought A diagnostic pitfall? World J Surg. 37:1701–1706.
2013.PubMed/NCBI View Article : Google Scholar
|
10
|
Vaughan A, Dietz JR, Moley JF, Debenedetti
MK, Aft RL, Gillanders WE, Eberlein TJ, Ritter J and Margenthaler
JA: Metastatic disease to the breast: The Washington university
experience. World J Surg Oncol. 5(74)2007.PubMed/NCBI View Article : Google Scholar
|
11
|
Travis WD: Pathology and diagnosis of
neuroendocrine tumors: Lung neuroendocrine. Thorac Surg Clin.
24:257–266. 2014.PubMed/NCBI View Article : Google Scholar
|
12
|
Vizcaíno I, Torregrosa A, Higueras V,
Morote V, Cremades A, Torres V, Olmos S and Molins C: Metastasis to
the breast from extramammary malignancies: A report of four cases
and a review of literature. Eur Radiol. 11:1659–1665.
2001.PubMed/NCBI View Article : Google Scholar
|
13
|
Toombs BD and Kalisher L: Metastatic
disease to the breast: Clinical, pathologic, and radiographic
features. AJR Am J Roentgenol. 129:673–676. 1977.PubMed/NCBI View Article : Google Scholar
|
14
|
Gomez DR, Blumenschein GR Jr, Lee JJ,
Hernandez M, Ye R, Camidge DR, Doebele RC, Skoulidis F, Gaspar LE,
Gibbons DL, et al: Local consolidative therapy versus maintenance
therapy or observation for patients with oligometastatic
non-small-cell lung cancer without progression after first-line
systemic therapy: A multicentre, randomised, controlled, phase 2
study. Lancet Oncol. 17:1672–1682. 2016.PubMed/NCBI View Article : Google Scholar
|
15
|
Matsuguma H, Nakahara R, Wakamatsu I,
Kishikawa T, Sugiyama T, Nakamura Y, Kasai T, Kamiyama Y, Hoshi N,
Inoue K, et al: Definitive local therapy for oligo-recurrence in
patients with completely resected non-small cell lung cancer. Am J
Clin Oncol. 43:210–217. 2020.PubMed/NCBI View Article : Google Scholar
|